Dr. Yu- Chieh Tsai
Claim this profileNational Taiwan University Hospital
Studies Skin Cancer
Studies Transitional Cell Carcinoma
1 reported clinical trial
4 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
2Transitional Cell Carcinoma
Stage IV
Stage III
More about Yu- Chieh Tsai
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Yu- Chieh Tsai has experience with
- Avelumab
- M6223
- NKTR-255
- Sacituzumab Govitecan
Breakdown of trials Yu- Chieh Tsai has run
Skin Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yu- Chieh Tsai specialize in?
Yu- Chieh Tsai focuses on Skin Cancer and Transitional Cell Carcinoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Yu- Chieh Tsai currently recruiting for clinical trials?
No, Yu- Chieh Tsai is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Yu- Chieh Tsai has studied deeply?
Yes, Yu- Chieh Tsai has studied treatments such as Avelumab, M6223, NKTR-255.
What is the best way to schedule an appointment with Yu- Chieh Tsai?
Apply for one of the trials that Yu- Chieh Tsai is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.